Total Payments
$4,644
2024 Payments
$185.41
Companies
14
Transactions
80
Medicare Patients
255
Medicare Billing
$60,423
Payment Breakdown by Category
Food & Beverage$4,644 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,644 | 80 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,641 | 25 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $1,207 | 15 | $0 (2024) |
| GlaxoSmithKline, LLC. | $534.04 | 8 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $400.47 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $174.00 | 2 | $0 (2017) |
| Amarin Pharma Inc. | $125.00 | 1 | $0 (2019) |
| Horizon Pharma plc | $121.73 | 1 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $102.03 | 4 | $0 (2019) |
| Novo Nordisk Inc | $101.28 | 2 | $0 (2019) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $99.34 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $185.41 | 4 | AstraZeneca Pharmaceuticals LP ($132.43) |
| 2023 | $789.93 | 13 | AstraZeneca Pharmaceuticals LP ($381.21) |
| 2022 | $230.48 | 9 | Bayer HealthCare Pharmaceuticals Inc. ($208.01) |
| 2021 | $246.31 | 3 | GlaxoSmithKline, LLC. ($123.40) |
| 2020 | $31.82 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($31.82) |
| 2019 | $879.06 | 15 | Boehringer Ingelheim Pharmaceuticals, Inc. ($456.41) |
| 2018 | $534.97 | 6 | Boehringer Ingelheim Pharmaceuticals, Inc. ($268.44) |
| 2017 | $1,746 | 28 | Boehringer Ingelheim Pharmaceuticals, Inc. ($854.18) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: Cardio-renal | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $118.97 | General |
| Category: Respiratory | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Respiratory | ||||||
| 08/01/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/05/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $108.92 | General |
| 10/05/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $12.04 | General |
| 07/11/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 06/15/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $9.51 | General |
| Category: Cardio-renal | ||||||
| 05/03/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 04/24/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Cardio-renal | ||||||
| 03/22/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $101.92 | General |
| 03/22/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $23.08 | General |
| 03/02/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $121.89 | General |
| Category: Cardio-renal | ||||||
| 02/23/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/21/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: Cardio-renal | ||||||
| 01/25/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $6.82 | General |
| Category: Cardio-renal | ||||||
| 01/12/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2022 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Diabetes | ||||||
| 11/15/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Cardio-renal | ||||||
| 10/22/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $110.00 | General |
| Category: Cardio-renal | ||||||
| 09/15/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Cardio-renal | ||||||
| 08/23/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Cardio-renal | ||||||
| 05/10/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Cardio-renal | ||||||
| 04/21/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Cardio-renal | ||||||
| 01/25/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 41 | 105 | $18,490 | $11,152 |
| 2022 | 4 | 73 | 181 | $30,730 | $17,110 |
| 2021 | 5 | 75 | 173 | $30,570 | $17,603 |
| 2020 | 5 | 66 | 169 | $27,025 | $14,559 |
Total Patients
255
Total Services
628
Medicare Billing
$60,423
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 74 | $11,840 | $7,377 | 62.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 16 | $4,400 | $2,325 | 52.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 13 | 15 | $2,250 | $1,450 | 64.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 98 | $15,680 | $8,454 | 53.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 45 | $6,975 | $3,794 | 54.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 19 | $5,225 | $3,166 | 60.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 19 | 19 | $2,850 | $1,696 | 59.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 67 | $10,720 | $5,920 | 55.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 55 | $8,525 | $4,976 | 58.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 18 | 18 | $4,500 | $2,639 | 58.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 12 | 15 | $4,125 | $2,415 | 58.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 14 | 18 | $2,700 | $1,652 | 61.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 14 | 84 | $13,440 | $7,537 | 56.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 13 | 14 | $3,850 | $2,414 | 62.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 33 | $5,115 | $2,392 | 46.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 12 | 14 | $2,100 | $1,303 | 62.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 24 | $2,520 | $912.05 | 36.2% |
About Dr. Henrico Mungcal, M.D
Dr. Henrico Mungcal, M.D is a General Practice healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750326609.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Henrico Mungcal, M.D has received a total of $4,644 in payments from pharmaceutical and medical device companies, with $185.41 received in 2024. These payments were reported across 80 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($4,644).
As a Medicare-enrolled provider, Mungcal has provided services to 255 Medicare beneficiaries, totaling 628 services with total Medicare billing of $60,423. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Location Long Beach, CA
- Active Since 06/17/2006
- Last Updated 03/14/2013
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750326609
Products in Payments
- JARDIANCE (Drug) $1,074
- Kerendia (Drug) $400.47
- BEVESPI AEROSPHERE (Drug) $275.39
- FARXIGA (Drug) $248.84
- BREZTRI (Drug) $231.57
- SPIRIVA RESPIMAT (Drug) $132.50
- Vascepa (Drug) $125.00
- ANORO ELLIPTA (Drug) $124.89
- TRELEGY ELLIPTA (Drug) $123.40
- KRYSTEXXA (Drug) $121.73
- AIRSUPRA (Drug) $118.97
- SYMBICORT (Drug) $117.75
- STIOLTO RESPIMAT (Drug) $104.81
- INVOKANA (Drug) $87.39
- Victoza (Drug) $86.98
- XARELTO (Drug) $86.61
- TOUJEO (Drug) $75.79
- JANUVIA (Drug) $58.19
- ANORO (Drug) $39.79
- STIOLTO (Drug) $39.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Long Beach
Dr. Robert Campbell, D.d.s, D.D.S
General Practice — Payments: $610,386
General Practice $610,386
Dr. Michael Jensen, D.d.s, D.D.S
General Practice — Payments: $17,472
General Practice $17,472
Dr. Marc Lapinel, Dds, DDS
General Practice — Payments: $8,283
General Practice $8,283
Jeffrey Cohen, D.d.s, D.D.S
General Practice — Payments: $6,571
General Practice $6,571
Dr. Atef Boutros, Dds, DDS
General Practice — Payments: $6,405
General Practice $6,405
Dr. Michael Cogan, Md, MD
General Practice — Payments: $3,261
General Practice $3,261